It is well known that CXCR3 facilitates Th1 and Teffs recruitment to the site of inflammation and facilitates Tregs recruitment to the same site, thus limiting the effectiveness of CXCR3+Teffs function in anti-tumor immunity. This evidence concerns the gene CXCR3 and neoplasm.